Blue Lake Biotechnology Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $10M

Blue Lake Biotechnology General Information

Description

Developer of intranasal vaccines designed to protect the public from life-threatening diseases. The company uses a proprietary canine parainfluenza virus that undergoes several rounds of self-limited replication to induce immune responses, often with just a single dose, enabling doctors to provide a defense against infection and help reduce the spread of disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 111 Riverbend Road
  • Athens, GA 30602
  • United States
+1 (706)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 111 Riverbend Road
  • Athens, GA 30602
  • United States
+1 (706)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Blue Lake Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 08-Nov-2022 $10M Completed Clinical Trials - Phase 2
1. Seed Round 06-Nov-2020 Completed Clinical Trials - Phase 2
To view Blue Lake Biotechnology’s complete valuation and funding history, request access »

Blue Lake Biotechnology Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Blue Lake Biotechnology’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Blue Lake Biotechnology Patents

Blue Lake Biotechnology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023372210-A1 Recombinant rsv vaccine: methods of making and using the same Pending 04-Nov-2022
EP-4611804-A1 Recombinant rsv vaccine: methods of making and using the same Pending 04-Nov-2022
US-12779029-B2 Recombinant rsv vaccine: methods of making and using the same Active 04-Nov-2022
US-20240148857-A1 Recombinant rsv vaccine: methods of making and using the same Active 04-Nov-2022
US-20260193671-A1 Recombinant rsv vaccine: methods of making and using the same Pending 04-Nov-2022 C12N15/86
To view Blue Lake Biotechnology’s complete patent history, request access »

Blue Lake Biotechnology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Blue Lake Biotechnology FAQs

  • When was Blue Lake Biotechnology founded?

    Blue Lake Biotechnology was founded in 2019.

  • Where is Blue Lake Biotechnology headquartered?

    Blue Lake Biotechnology is headquartered in Athens, GA.

  • What is the size of Blue Lake Biotechnology?

    Blue Lake Biotechnology has 15 total employees.

  • What industry is Blue Lake Biotechnology in?

    Blue Lake Biotechnology’s primary industry is Drug Discovery.

  • Is Blue Lake Biotechnology a private or public company?

    Blue Lake Biotechnology is a Private company.

  • What is Blue Lake Biotechnology’s current revenue?

    The current revenue for Blue Lake Biotechnology is .

  • How much funding has Blue Lake Biotechnology raised over time?

    Blue Lake Biotechnology has raised $18.8M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process